The Mystery of Rap1 Suppression of Oncogenic Ras

Kitayama, 1989, A ras-related gene with transformation suppressor activity, Cell, 56, 77, 10.1016/0092-8674(89)90985-9

Cook, 1993, RapV12 antagonizes Ras-dependent activation of ERK1 and ERK2 by LPA and EGF in Rat-1 fibroblasts, EMBO J., 12, 3475, 10.1002/j.1460-2075.1993.tb06022.x

Sprang, 1995, How Ras works: structure of a Rap–Raf complex, Structure, 3, 641, 10.1016/S0969-2126(01)00198-8

Zwartkruis, 1999, Ras and Rap1: two highly related small GTPases with distinct function, Exp. Cell Res., 253, 157, 10.1006/excr.1999.4695

Shah, 2019, Ras and Rap1: a tale of two GTPases, Semin. Cancer Biol., 54, 29, 10.1016/j.semcancer.2018.03.005

Bos, 1998, All in the family? New insights and questions regarding interconnectivity of Ras, Rap1 and Ral, EMBO J., 17, 6776, 10.1093/emboj/17.23.6776

Caron, 2003, Cellular functions of the Rap1 GTP-binding protein: a pattern emerges, J. Cell Sci., 116, 435, 10.1242/jcs.00238

Chang, 2019, Molecular basis for autoinhibition of RIAM regulated by FAK in integrin activation, Proc. Natl. Acad. Sci. U. S. A., 116, 3524, 10.1073/pnas.1818880116

Zeiller, 2012, Ras and Rap1 govern spatiotemporal dynamic of activated ERK in pituitary living cells, Cell. Signal., 24, 2237, 10.1016/j.cellsig.2012.08.006

Su, 2015, Rap1 and its effector RIAM are required for lymphocyte trafficking, Blood, 126, 2695, 10.1182/blood-2015-05-644104

York, 1998, Rap1 mediates sustained MAP kinase activation induced by nerve growth factor, Nature, 392, 622, 10.1038/33451

Bos, 2001, Rap1 signalling: adhering to new models, Nat. Rev. Mol. Cell Biol., 2, 369, 10.1038/35073073

Knox, 2002, Rap1 GTPase regulation of adherens junction positioning and cell adhesion, Science, 295, 1285, 10.1126/science.1067549

Wittchen, 2011, Isoform-specific differences between Rap1A and Rap1B GTPases in the formation of endothelial cell junctions, Small GTPases, 2, 65, 10.4161/sgtp.2.2.15735

Jeyaraj, 2011, Rap1 GTPases: an emerging role in the cardiovasculature, Life Sci., 88, 645, 10.1016/j.lfs.2011.01.023

Bos, 2005, Linking Rap to cell adhesion, Curr. Opin. Cell Biol., 17, 123, 10.1016/j.ceb.2005.02.009

Jeon, 2007, Rap1 controls cell adhesion and cell motility through the regulation of myosin II, J. Cell Biol., 176, 1021, 10.1083/jcb.200607072

Arthur, 2004, Rap1 promotes cell spreading by localizing Rac guanine nucleotide exchange factors, J. Cell Biol., 167, 111, 10.1083/jcb.200404068

Lakshmikanthan, 2011, Rap1 promotes VEGFR2 activation and angiogenesis by a mechanism involving integrin αvβ3, Blood, 118, 2015, 10.1182/blood-2011-04-349282

Bailey, 2009, Activation of Rap1 promotes prostate cancer metastasis, Cancer Res., 69, 4962, 10.1158/0008-5472.CAN-08-4269

Wittchen, 2013, Rap1 GTPase activation and barrier enhancement in RPE inhibits choroidal neovascularization in vivo, PLoS One, 8, 10.1371/journal.pone.0073070

Lu, 2016, Rap1A promotes ovarian cancer metastasis via activation of ERK/p38 and notch signaling, Cancer Med., 5, 3544, 10.1002/cam4.946

Jordan, 1999, Modulation of rap activity by direct interaction of Gαo with Rap1 GTPase-activating protein, J. Biol. Chem., 274, 21507, 10.1074/jbc.274.31.21507

Nussinov, 2019, Is nanoclustering essential for all oncogenic KRas pathways? Can it explain why wild-type KRas can inhibit its oncogenic variant?, Semin. Cancer Biol., 54, 114, 10.1016/j.semcancer.2018.01.002

Nussinov, 2018, Oncogenic Ras isoforms signaling specificity at the membrane, Cancer Res., 78, 593, 10.1158/0008-5472.CAN-17-2727

Hu, 1997, Coassociation of Rap1A and Ha-Ras with Raf-1 N-terminal region interferes with Ras-dependent activation of Raf-1, J. Biol. Chem., 272, 11702, 10.1074/jbc.272.18.11702

Stork, 2005, Directing NGF's actions: it's a Rap, Nat. Cell Biol., 7, 338, 10.1038/ncb0405-338

Stork, 2003, Does Rap1 deserve a bad Rap?, Trends Biochem. Sci., 28, 267, 10.1016/S0968-0004(03)00087-2

Hattori, 2003, Rap1 GTPase: functions, regulation, and malignancy, J. Biochem., 134, 479, 10.1093/jb/mvg180

Boriack-Sjodin, 1998, The structural basis of the activation of Ras by Sos, Nature, 394, 337, 10.1038/28548

Cherfils, 2013, Regulation of small GTPases by GEFs, GAPs, and GDIs, Physiol. Rev., 93, 269, 10.1152/physrev.00003.2012

Hancock, 1989, All ras proteins are polyisoprenylated but only some are palmitoylated, Cell, 57, 1167, 10.1016/0092-8674(89)90054-8

Jang, 2016, The higher level of complexity of K-Ras4B activation at the membrane, FASEB J., 30, 1643, 10.1096/fj.15-279091

Schmick, 2014, KRas localizes to the plasma membrane by spatial cycles of solubilization, trapping and vesicular transport, Cell, 157, 459, 10.1016/j.cell.2014.02.051

Zhou, 2015, Ras nanoclusters: versatile lipid-based signaling platforms, Biochim. Biophys. Acta, 1853, 841, 10.1016/j.bbamcr.2014.09.008

Nussinov, 2019, Oncogenic KRas mobility in the membrane and signaling response, Semin. Cancer Biol., 54, 109, 10.1016/j.semcancer.2018.02.009

Muratcioglu, 2017, PDEδ binding to Ras isoforms provides a route to proper membrane localization, J. Phys. Chem. B, 121, 5917, 10.1021/acs.jpcb.7b03035

Jang, 2016, Membrane-associated Ras dimers are isoform-specific: K-Ras dimers differ from H-Ras dimers, Biochem. J., 473, 1719, 10.1042/BCJ20160031

Bandaru, 2019, The interdependent activation of Son-of-Sevenless and Ras, Cold Spring Harb. Perspect. Med., 9, 10.1101/cshperspect.a031534

Rezaei Adariani, 2018, Structural snapshots of RAF kinase interactions, Biochem. Soc. Trans., 46, 1393, 10.1042/BST20170528

Tsai, 2018, Allosteric activation of RAF in the MAPK signaling pathway, Curr. Opin. Struct. Biol., 53, 100, 10.1016/j.sbi.2018.07.007

Yuan, 2018, The dimer-dependent catalytic activity of RAF family kinases is revealed through characterizing their oncogenic mutants, Oncogene, 37, 5719, 10.1038/s41388-018-0365-2

Lavoie, 2018, MEK drives BRAF activation through allosteric control of KSR proteins, Nature, 554, 549, 10.1038/nature25478

Varga, 2017, RAF1/BRAF dimerization integrates the signal from RAS to ERK and ROKα, Sci. Signal., 10, 10.1126/scisignal.aai8482

Verkhivker, 2016, Molecular dynamics simulations and modelling of the residue interaction networks in the BRAF kinase complexes with small molecule inhibitors: probing the allosteric effects of ligand-induced kinase dimerization and paradoxical activation, Mol. BioSyst., 12, 3146, 10.1039/C6MB00298F

Jambrina, 2016, Phosphorylation of RAF kinase dimers drives conformational changes that facilitate transactivation, Angew. Chem. Int. Ed. Engl., 55, 983, 10.1002/anie.201509272

Freeman, 2013, The importance of Raf dimerization in cell signaling, Small GTPases, 4, 180, 10.4161/sgtp.26117

Freeman, 2013, Effects of Raf dimerization and its inhibition on normal and disease-associated Raf signaling, Mol. Cell, 49, 751, 10.1016/j.molcel.2012.12.018

Udell, 2011, Mechanistic principles of RAF kinase signaling, Cell. Mol. Life Sci., 68, 553, 10.1007/s00018-010-0520-6

Zhang, 2019, The structural basis for Ras activation of PI3Kα lipid kinase, Phys. Chem. Chem. Phys., 21, 12021, 10.1039/C9CP00101H

Spandidos, 1988, The normal human H-ras1 gene can act as an onco-suppressor, Br. J. Cancer Suppl., 9, 67

Spandidos, 1990, Expression of the normal H-ras1 gene can suppress the transformed and tumorigenic phenotypes induced by mutant ras genes, Anticancer Res., 10, 1543

Diaz, 2002, The N-ras proto-oncogene can suppress the malignant phenotype in the presence or absence of its oncogene, Cancer Res., 62, 4514

Zhang, 2001, Wildtype Kras2 can inhibit lung carcinogenesis in mice, Nat. Genet., 29, 25, 10.1038/ng721

To, 2013, Interactions between wild-type and mutant Ras genes in lung and skin carcinogenesis, Oncogene, 32, 4028, 10.1038/onc.2012.404

Zhou, 2016, The role of wild type RAS isoforms in cancer, Semin. Cell Dev. Biol., 58, 60, 10.1016/j.semcdb.2016.07.012

Staffas, 2015, Wild-type KRAS inhibits oncogenic KRAS-induced T-ALL in mice, Leukemia, 29, 1032, 10.1038/leu.2014.315

Kong, 2016, Loss of wild-type Kras promotes activation of all Ras isoforms in oncogenic Kras-induced leukemogenesis, Leukemia, 30, 1542, 10.1038/leu.2016.40

Qiu, 2011, Disruption of p16 and activation of Kras in pancreas increase ductal adenocarcinoma formation and metastasis in vivo, Oncotarget, 2, 862, 10.18632/oncotarget.357

Matallanas, 2011, Mutant K-Ras activation of the proapoptotic MST2 pathway is antagonized by wild-type K-Ras, Mol. Cell, 44, 893, 10.1016/j.molcel.2011.10.016

Henis, 2009, Ras acylation, compartmentalization and signaling nanoclusters (review), Mol. Membr. Biol., 26, 80, 10.1080/09687680802649582

Nussinov, 2015, Oligomerization and nanocluster organization render specificity, Biol. Rev. Camb. Philos. Soc., 90, 587, 10.1111/brv.12124

Nussinov, 2018, Autoinhibition in Ras effectors Raf, PI3Kα, and RASSF5: a comprehensive review underscoring the challenges in pharmacological intervention, Biophys. Rev., 10, 1263, 10.1007/s12551-018-0461-0

Kondo, 2019, Cryo-EM structure of a dimeric B-Raf:14-3-3 complex reveals asymmetry in the active sites of B-Raf kinases, Science, 366, 109, 10.1126/science.aay0543

Park, 2019, Architecture of autoinhibited and active BRAF-MEK1-14-3-3 complexes, Nature, 575, 545, 10.1038/s41586-019-1660-y

Lavoie, 2015, Regulation of RAF protein kinases in ERK signalling, Nat. Rev. Mol. Cell Biol., 16, 281, 10.1038/nrm3979

Nussinov, 2019, Does Ras activate Raf and PI3K allosterically?, Front. Oncol., 9, 1231, 10.3389/fonc.2019.01231

Brtva, 1995, Two distinct Raf domains mediate interaction with Ras, J. Biol. Chem., 270, 9809, 10.1074/jbc.270.17.9809

Drugan, 1996, Ras interaction with two distinct binding domains in Raf-1 may be required for Ras transformation, J. Biol. Chem., 271, 233, 10.1074/jbc.271.1.233

Hu, 1995, Cysteine-rich region of Raf-1 interacts with activator domain of post-translationally modified Ha-Ras, J. Biol. Chem., 270, 30274, 10.1074/jbc.270.51.30274

Morrison, 1997, The complexity of Raf-1 regulation, Curr. Opin. Cell Biol., 9, 174, 10.1016/S0955-0674(97)80060-9

Moodie, 1993, Complexes of Ras. GTP with Raf-1 and mitogen-activated protein kinase, Science, 260, 1658, 10.1126/science.8503013

Herrmann, 1996, Differential interaction of the Ras family GTP-binding proteins H-Ras, Rap1A, and R-Ras with the putative effector molecules Raf kinase and Ral-guanine nucleotide exchange factor, J. Biol. Chem., 271, 6794, 10.1074/jbc.271.12.6794

Nassar, 1996, Ras/Rap effector specificity determined by charge reversal, Nat. Struct. Biol., 3, 723, 10.1038/nsb0896-723

Vetter, 1999, Structural and biochemical analysis of Ras-effector signaling via RalGDS, FEBS Lett., 451, 175, 10.1016/S0014-5793(99)00555-4

Li, 2018, Raf-1 cysteine-rich domain increases the affinity of K-Ras/Raf at the membrane, promoting MAPK signaling, Structure, 26, 513, 10.1016/j.str.2018.01.011

Liao, 2016, RASSF5: An MST activator and tumor suppressor in vivo but opposite in vitro, Curr. Opin. Struct. Biol., 41, 217, 10.1016/j.sbi.2016.09.001

Zhou, 2018, Electron microscopy combined with spatial analysis: quantitative mapping of the nano-assemblies of plasma membrane-associating proteins and lipids, Biophys. Rep., 4, 320, 10.1007/s41048-018-0060-4

Lou, 2019, A bounty of new challenging targets in oncology for chemical discovery, Biochemistry, 58, 3328, 10.1021/acs.biochem.9b00570

Zhao, 2014, Exploration of type II binding mode: a privileged approach for kinase inhibitor focused drug discovery?, ACS Chem. Biol., 9, 1230, 10.1021/cb500129t

Roskoski, 2019, Targeting ERK1/2 protein-serine/threonine kinases in human cancers, Pharmacol. Res., 142, 151, 10.1016/j.phrs.2019.01.039

Gao, 2013, Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal, Sci. Signal., 6, 10.1126/scisignal.2004088